Label: STRONGID T- pyrantel pamoate suspension

  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Animal Drug Application

Drug Label Information

Updated 08/10

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Equine Anthelmintic Suspension

    Close
  • CAUTION

    Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Close
  • DESCRIPTION

    Strongid T is a suspension of pyrantel pamoate in a palatable caramel-flavored vehicle. Each mL contains 50 mg of pyrantel base as pyrantel pamoate.

    Pyrantel pamoate is a compound belonging to a family classified chemically as tetrahydropyrimidines. It is a yellow, water-insoluble crystalline salt of the tetrahydropyrimidine base and pamoic acid containing 34.7% base activity. The chemical structure and name are given below:

    Chemical Structure

    (E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl) vinyl] pyrimidine 4,4' methylenebis[3-hydroxy-2-naphthoate] (1:1)

    Close
  • INDICATIONS AND USAGE

    For the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); pinworms (Oxyuris equi); large roundworms (Parascaris equorum); and small strongyles in horses and ponies.

    Close
  • CONTRAINDICATIONS

    It is recommended that severely debilitated animals not be treated with this preparation.

    Close
  • WARNINGS

    Do not use in horses intended for human consumption. Keep out of reach of children.

    Close
  • PRECAUTION

    This product is a suspension and as such will separate. To insure uniform resuspension and to achieve proper dosage, it is extremely important that the product be shaken and stirred thoroughly before every use.

    Close
  • DOSAGE AND ADMINISTRATION

    Administer 3 mg pyrantel base per lb of body weight (6 mL Strongid T per 100 lb of body weight). For maximum control of parasitism, it is recommended that foals (2–8 months of age) be dosed every 4 weeks. To minimize potential hazard that the mare may pose to the foal, she should be treated 1 month prior to anticipated foaling date followed by retreatment 10 days to 2 weeks after birth of foal. Horses over 8 months of age should be routinely dosed every 6 weeks.

    Directions for use

    Strongid T may be administered by means of a stomach tube, dose syringe or by mixing into the feed.

    Stomach Tube

    Measure the appropriate dosage of Strongid T and mix in the desired quantity of water. Protect drench from direct sunlight and administer to the animal immediately following mixing. Do not attempt to store diluted suspension.

    Strongid T is inactive against the common horse bot (Gasterophilus spp.) However, Strongid T may be administered concurrently with carbon disulfide observing the usual precautions with carbon disulfide.

    Dose Syringe

    Draw the appropriate dosage of Strongid T into a dose syringe and administer to the animal. Do not expose Strongid T to direct sunlight.

    Feed

    Mix the appropriate dosage of Strongid T in the normal grain ration. Fasting of animals prior to or following treatment is not required.

    Close
  • EFFICACY

    Critical (worm-count) studies in horses demonstrated that Strongid T administered at the recommended dosage was efficacious against mature infections of Strongylus vulgaris (>90%), S. edentatus (69%), S. equinus (>90%), Oxyuris equi (81%), Parascaris equorum (>90%), and small strongyles (90%).

    Close
  • SAFETY

    Strongid T is well tolerated by horses and ponies of all ages. No adverse drug response was observed when dose rates up to 60 mg of pyrantel base per lb of body weight were administered by stomach tube nor when 3 mg base per lb was given by intratracheal injection. The reproductive performance of pregnant mares and stud horses dosed with Strongid T has not been affected.

    Close
  • RECOMMENDED STORAGE

    Store below 30°C (86°F).

    Close
  • HOW SUPPLIED

    Strongid T is supplied in 1 quart (946 mL) bottles.

    Close
  • SPL UNCLASSIFIED SECTION

    NADA #91-739, Approved by FDA

    TAKE TIME OBSERVE LABEL DIRECTIONS

    Distributed by:
    Pfizer Animal Health
    Div. of Pfizer Inc
    NY, NY 10017

    10232100
    81463930
    Printed in USA

    Close
  • PRINCIPAL DISPLAY PANEL - 946 mL Bottle Label

    Strongid® T
    (pyrantel pamoate)

    Equine
    Anthelmintic
    Suspension

    Active Ingredient: 50 mg of pyrantel
    base as pyrantel pamoate per mL

    Caution: Federal law restricts this
    drug to use by or on the order of
    a licensed veterinarian.

    Net Contents: 1 quart (946 mL)

    NADA #91-739, Approved by FDA

    Pfizer

    PRINCIPAL DISPLAY PANEL - 946 mL Bottle Label
    Close
  • INGREDIENTS AND APPEARANCE
    STRONGID T 
    pyrantel pamoate suspension
    Product Information
    Product Type PRESCRIPTION ANIMAL DRUG LABEL Item Code (Source) NDC:61106-2384
    Route of Administration ORAL DEA Schedule     
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    pyrantel pamoate (pyrantel) pyrantel 50 mg  in 1 mL
    Product Characteristics
    Color      Score     
    Shape Size
    Flavor CARAMEL Imprint Code
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:61106-2384-1 946 mL in 1 BOTTLE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    NADA NADA091739 10/19/1973
    Labeler - Pfizer Animal Health (039055157)
    Establishment
    Name Address ID/FEI Business Operations
    Pfizer Animal Health 039055157 MANUFACTURE
    Close